نتایج جستجو برای: methyl prednisolone

تعداد نتایج: 117214  

2017
Mohammad Emami Ardestani Elham Kalantary Vajihe Samaiy Keramat Taherian

INTRODUCTION Corticosteroids are routinely used in management of chronic obstructive pulmonary disease (COPD) exacerbation. The main purpose of present study was to compare the efficacy of methyl prednisolone (MP) and dexamethasone (DXM) for this purpose. METHODS Adult COPD patients entered the present clinical trial. All patients received standard treatment on admission and were then divided...

2017
Lieven Van Meulebroek Nathalie De Clercq Julie Vanden Bussche Mathias Devreese Eric Fichant Philippe Delahaut Siska Croubels Lynn Vanhaecke

BACKGROUND In Europe, synthetic corticosteroids are not allowed in animal breeding for growth-promoting purposes. Nevertheless, a high prevalence of non-compliant urine samples was recently reported for prednisolone, however, without any indication of unauthorized use. Within this context, 20β-dihydroprednisolone and the prednisolone/cortisol ratio have been suggested as potential tools to disc...

Journal: :Acta medica Okayama 2001
T Takenami K Sakaguchi M Nishimura Y Miyake M Miyashita M Terao A Fujiwara T Tsuji

This study evaluated the effects of azathioprine in combination with low-dose prednisolone in the management of patients with intractable autoimmune hepatitis. Thirteen patients with intractable autoimmune hepatitis who had an incomplete or arrested response to conventional prednisolone therapy, or who relapsed during prednisolone maintenance therapy were additionally administered 50 or 100 mg/...

2013

Prednisolone Sodium Phosphate Oral Solution is a dye free, colorless to light straw-colored, raspberry flavored solution. Each 5 mL (teaspoonful) of Prednisolone Sodium Phosphate Oral Solution contains 6.7 mg prednisolone sodium phosphate (5 mg prednisolone base) in a palatable, aqueous vehicle. Prednisolone Sodium Phosphate Oral Solution also contains dibasic sodium phosphate, edetate disodium...

2003
P S Burge

Background: A trial of corticosteroids has been recommended for all patients with chronic obstructive pulmonary disease (COPD), with the subsequent “response” determining the treatment selected. This approach assumes that patients can be reliably divided into responder and non-responder groups. We have assessed whether such a separation is statistically valid, which factors influence the change...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید